{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:33:26Z","timestamp":1785537206275,"version":"3.56.0"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2022YFA1303500-003"],"award-info":[{"award-number":["2022YFA1303500-003"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["L192065"],"award-info":[{"award-number":["L192065"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["7212103"],"award-info":[{"award-number":["7212103"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.intimp.2023.109728","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T03:14:05Z","timestamp":1673406845000},"page":"109728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Developing a multiepitope vaccine for the prevention of SARS-CoV-2 and monkeypox virus co-infection: A reverse vaccinology analysis"],"prefix":"10.1016","volume":"115","author":[{"given":"Fan","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqi","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenping","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"27","key":"10.1016\/j.intimp.2023.109728_b0005","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.intimp.2023.109728_b0010","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"10277","key":"10.1016\/j.intimp.2023.109728_b0015","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(21)00432-3","article-title":"Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2023.109728_b0020","article-title":"J&J's one-shot COVID vaccine offers hope for faster protection","author":"Ledford","year":"2021","journal-title":"Nature"},{"issue":"10275","key":"10.1016\/j.intimp.2023.109728_b0025","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(21)00234-8","article-title":"Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia","volume":"397","author":"Logunov","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.intimp.2023.109728_b0030","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taab051","article-title":"Inactivated COVID-19 vaccine BBV152\/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2","volume":"28","author":"Sapkal","year":"2021","journal-title":"J. Travel Med."},{"issue":"2","key":"10.1016\/j.intimp.2023.109728_b0035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41591-021-01230-y","article-title":"Looking beyond COVID-19 vaccine phase 3 trials","volume":"27","author":"Kim","year":"2021","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.intimp.2023.109728_b0040","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJMoa2116185","article-title":"Efficacy and safety of NVX-CoV2373 in adults in the United States and Mexico","volume":"386","author":"Dunkle","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.intimp.2023.109728_b0045","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1056\/NEJMoa2107659","article-title":"Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine","volume":"385","author":"Heath","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.intimp.2023.109728_b0050","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa2103055","article-title":"Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant","volume":"384","author":"Shinde","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2023.109728_b0055","doi-asserted-by":"crossref","unstructured":"A. Barchuk et al., Gam-COVID-Vac, EpiVacCorona, and CoviVac effectiveness against lung injury during Delta and Omicron variant surges in St.Petersburg, Russia: a test-negative case-control study, Respir. Res. 23(1) (2022) 276.","DOI":"10.1186\/s12931-022-02206-3"},{"issue":"7","key":"10.1016\/j.intimp.2023.109728_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071652","article-title":"Covid-19, Renin-angiotensin system and endothelial dysfunction","volume":"9","author":"Amraei","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2023.109728_b0065","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.cca.2020.08.013","article-title":"Potential diagnostics and therapeutic approaches in COVID-19","volume":"510","author":"Kumari","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"6","key":"10.1016\/j.intimp.2023.109728_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/v13061115","article-title":"The SARS-CoV-2 nucleocapsid protein and its role in viral structure, biological functions, and a potential target for drug or vaccine mitigation","volume":"13","author":"Bai","year":"2021","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.intimp.2023.109728_b0075","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s43440-020-00195-y","article-title":"Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes","volume":"73","author":"Kaur","year":"2021","journal-title":"Pharmacol. Rep."},{"issue":"5","key":"10.1016\/j.intimp.2023.109728_b0080","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02160-20","article-title":"Immunologic testing for SARS-CoV-2 infection from the antigen perspective","volume":"59","author":"Li","year":"2021","journal-title":"J. Clin. Microbiol."},{"issue":"9","key":"10.1016\/j.intimp.2023.109728_b0085","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","article-title":"Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.intimp.2023.109728_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/v13010109","article-title":"Domains and functions of spike protein in Sars-Cov-2 in the context of vaccine design","volume":"13","author":"Xia","year":"2021","journal-title":"Viruses"},{"issue":"18","key":"10.1016\/j.intimp.2023.109728_b0095","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.3346\/jkms.2021.36.e124","article-title":"Will mutations in the spike protein of SARS-CoV-2 lead to the failure of COVID-19 vaccines?","volume":"36","author":"Jia","year":"2021","journal-title":"J. Korean Med. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2023.109728_b0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6585","key":"10.1016\/j.intimp.2023.109728_b0105","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1126\/science.abm8108","article-title":"The immunology and immunopathology of COVID-19","volume":"375","author":"Merad","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.intimp.2023.109728_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104390","article-title":"Exploring SARS-COV-2 structural proteins to design a multi-epitope vaccine using immunoinformatics approach: an in silico study","volume":"133","author":"Sanami","year":"2021","journal-title":"Comput. Biol. Med."},{"issue":"8","key":"10.1016\/j.intimp.2023.109728_b0115","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1473-3099(22)00228-6","article-title":"Clinical features and management of human monkeypox: a retrospective observational study in the UK","volume":"22","author":"Adler","year":"2022","journal-title":"Lancet Infect. Dis."},{"issue":"4","key":"10.1016\/j.intimp.2023.109728_b0120","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/jmv.25348","article-title":"A review of the monkeypox virus and a recent outbreak of skin rash disease in Nigeria","volume":"91","author":"Kabuga","year":"2019","journal-title":"J. Med. Virol."},{"issue":"8","key":"10.1016\/j.intimp.2023.109728_b0125","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox virus infection in humans across 16 countries - April-June 2022","volume":"387","author":"Thornhill","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2023.109728_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2022.102398","article-title":"Recently spreading human monkeypox virus infection and its transmission during COVID-19 pandemic period: a travelers' prospective","volume":"49","author":"Bhattacharya","year":"2022","journal-title":"Travel Med. Infect. Dis."},{"key":"10.1016\/j.intimp.2023.109728_b0135","unstructured":"WHO, Vaccines and immunization for monkeypox Interim guidance, W.H. Organization, Editor. 2022, World Health Organization: Geneva, p. 20."},{"key":"10.1016\/j.intimp.2023.109728_b0140","doi-asserted-by":"crossref","first-page":"1035924","DOI":"10.3389\/fimmu.2022.1035924","article-title":"Immuno-informatics profiling of monkeypox virus cell surface binding protein for designing a next generation multi-valent peptide-based vaccine","volume":"13","author":"Yousaf","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.109728_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2022.102481","article-title":"Designing, characterization, and immune stimulation of a novel multi-epitopic peptide-based potential vaccine candidate against monkeypox virus through screening its whole genome encoded proteins: an immunoinformatics approach","volume":"50","author":"Bhattacharya","year":"2022","journal-title":"Travel Med. Infect. Dis."},{"issue":"11","key":"10.1016\/j.intimp.2023.109728_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/v14112374","article-title":"Immunoinformatics-aided design of a peptide based multiepitope vaccine targeting glycoproteins and membrane proteins against Monkeypox virus","volume":"14","author":"Akhtar","year":"2022","journal-title":"Viruses"},{"issue":"13","key":"10.1016\/j.intimp.2023.109728_b0155","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1073\/pnas.2002616117","article-title":"Impact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak","volume":"117","author":"Wells","year":"2020","journal-title":"PNAS"},{"issue":"6","key":"10.1016\/j.intimp.2023.109728_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/v14061283","article-title":"Travel-related monkeypox outbreaks in the era of COVID-19 pandemic: are we prepared?","volume":"14","author":"Adegboye","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.intimp.2023.109728_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2022.102387","article-title":"Monkeypox and human transmission: Are we on the verge of another pandemic?","volume":"49","author":"Farahat","year":"2022","journal-title":"Travel Med. Infect. Dis."},{"issue":"11","key":"10.1016\/j.intimp.2023.109728_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/v14112504","article-title":"Multi-epitope vaccine for monkeypox using pan-genome and reverse vaccinology approaches","volume":"14","author":"Swetha","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.intimp.2023.109728_b0175","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.intimp.2023.109728_b0180","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1745-6150-8-30","article-title":"Designing of interferon-gamma inducing MHC class-II binders","volume":"8","author":"Dhanda","year":"2013","journal-title":"Biol. Direct"},{"issue":"7819","key":"10.1016\/j.intimp.2023.109728_b0185","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","article-title":"Human neutralizing antibodies elicited by SARS-CoV-2 infection","volume":"584","author":"Ju","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.intimp.2023.109728_b0190","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.immuni.2021.01.014","article-title":"B cell memory: understanding COVID-19","volume":"54","author":"Quast","year":"2021","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.intimp.2023.109728_b0195","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.immuni.2022.01.002","article-title":"Development of Tbet- and CD11c-expressing B cells in a viral infection requires T follicular helper cells outside of germinal centers","volume":"55","author":"Song","year":"2022","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2023.109728_b0200","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/prot.21078","article-title":"Prediction of continuous B-cell epitopes in an antigen using recurrent neural network","volume":"65","author":"Saha","year":"2006","journal-title":"Proteins"},{"issue":"1","key":"10.1016\/j.intimp.2023.109728_b0205","doi-asserted-by":"crossref","first-page":"21929","DOI":"10.1038\/s41598-021-01283-6","article-title":"An integrated computational framework to design a multi-epitopes vaccine against Mycobacterium tuberculosis","volume":"11","author":"Albutti","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2023.109728_b0210","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.meegid.2017.02.007","article-title":"A novel design of a multi-antigenic, multistage and multi-epitope vaccine against Helicobacter pylori: an in silico approach","volume":"49","author":"Meza","year":"2017","journal-title":"Infect. Genet. Evol."},{"issue":"43","key":"10.1016\/j.intimp.2023.109728_b0215","doi-asserted-by":"crossref","first-page":"15440","DOI":"10.1073\/pnas.0406740101","article-title":"A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses","volume":"101","author":"Jackson","year":"2004","journal-title":"PNAS"},{"issue":"23","key":"10.1016\/j.intimp.2023.109728_b0220","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1093\/bioinformatics\/btq551","article-title":"High-throughput prediction of protein antigenicity using protein microarray data","volume":"26","author":"Magnan","year":"2010","journal-title":"Bioinformatics"},{"issue":"6","key":"10.1016\/j.intimp.2023.109728_b0225","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1007\/s00894-014-2278-5","article-title":"AllerTOP vol 2\u2013a server for in silico prediction of allergens","volume":"20","author":"Dimitrov","year":"2014","journal-title":"J. Mol. Model."},{"issue":"6","key":"10.1016\/j.intimp.2023.109728_b0230","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/bioinformatics\/btt619","article-title":"AllergenFP: allergenicity prediction by descriptor fingerprints","volume":"30","author":"Dimitrov","year":"2014","journal-title":"Bioinformatics"},{"issue":"19","key":"10.1016\/j.intimp.2023.109728_b0235","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1093\/bioinformatics\/btx345","article-title":"Protein-Sol: a web tool for predicting protein solubility from sequence","volume":"33","author":"Hebditch","year":"2017","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.intimp.2023.109728_b0240","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/bioinformatics\/16.4.404","article-title":"The PSIPRED protein structure prediction server","volume":"16","author":"McGuffin","year":"2000","journal-title":"Bioinformatics"},{"key":"10.1016\/j.intimp.2023.109728_b0245","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0076-6879(96)66034-0","article-title":"GOR method for predicting protein secondary structure from amino acid sequence","volume":"266","author":"Garnier","year":"1996","journal-title":"Methods Enzymol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109728_b0250","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nmeth.3213","article-title":"The I-TASSER Suite: protein structure and function prediction","volume":"12","author":"Yang","year":"2015","journal-title":"Nat. Methods"},{"issue":"4","key":"10.1016\/j.intimp.2023.109728_b0255","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nprot.2010.5","article-title":"I-TASSER: a unified platform for automated protein structure and function prediction","volume":"5","author":"Roy","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.intimp.2023.109728_b0260","doi-asserted-by":"crossref","unstructured":"L. Heo, H. Park, C. Seok, GalaxyRefine: protein structure refinement driven by side-chain repacking, Nucl. Acids Res. 41(Web Server issue) (2013) W384-8.","DOI":"10.1093\/nar\/gkt458"},{"key":"10.1016\/j.intimp.2023.109728_b0265","doi-asserted-by":"crossref","unstructured":"M. Wiederstein, M.J. Sippl, ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins, Nucl. Acids Res. 35(Web Server issue) (2007) W407-10.","DOI":"10.1093\/nar\/gkm290"},{"issue":"9","key":"10.1016\/j.intimp.2023.109728_b0270","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/pro.5560020916","article-title":"Verification of protein structures: patterns of nonbonded atomic interactions","volume":"2","author":"Colovos","year":"1993","journal-title":"Protein Sci."},{"issue":"W1","key":"10.1016\/j.intimp.2023.109728_b0275","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.intimp.2023.109728_b0280","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/1471-2105-9-514","article-title":"ElliPro: a new structure-based tool for the prediction of antibody epitopes","volume":"9","author":"Ponomarenko","year":"2008","journal-title":"BMC Bioinf."},{"issue":"2","key":"10.1016\/j.intimp.2023.109728_b0285","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nprot.2016.169","article-title":"The ClusPro web server for protein-protein docking","volume":"12","author":"Kozakov","year":"2017","journal-title":"Nat. Protoc."},{"issue":"20","key":"10.1016\/j.intimp.2023.109728_b0290","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1093\/bioinformatics\/btr497","article-title":"iMod: multipurpose normal mode analysis in internal coordinates","volume":"27","author":"Lop\u00e9z-Blanco","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.intimp.2023.109728_b0295","doi-asserted-by":"crossref","unstructured":"J.R. L\u00f3pez-Blanco et al., iMODS: internal coordinates normal mode analysis server, Nucl. Acids Res. 42(Web Server issue) (2014) W271-6.","DOI":"10.1093\/nar\/gku339"},{"issue":"4","key":"10.1016\/j.intimp.2023.109728_b0300","doi-asserted-by":"crossref","first-page":"e9862","DOI":"10.1371\/journal.pone.0009862","article-title":"Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system","volume":"5","author":"Rapin","year":"2010","journal-title":"PLoS One"},{"issue":"Web Server issue","key":"10.1016\/j.intimp.2023.109728_b0305","doi-asserted-by":"crossref","first-page":"W126","DOI":"10.1093\/nar\/gkm219","article-title":"OPTIMIZER: a web server for optimizing the codon usage of DNA sequences","volume":"35","author":"Puigb\u00f2","year":"2007","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.intimp.2023.109728_b0310","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fbioe.2014.00041","article-title":"Computational tools and algorithms for designing customized synthetic genes","volume":"2","author":"Gould","year":"2014","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"Database issue","key":"10.1016\/j.intimp.2023.109728_b0315","first-page":"D524","article-title":"HEG-DB: a database of predicted highly expressed genes in prokaryotic complete genomes under translational selection","volume":"36","author":"Puigb\u00f2","year":"2008","journal-title":"Nucl. Acids Res."},{"issue":"1","key":"10.1016\/j.intimp.2023.109728_b0320","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/21645515.2020.1763693","article-title":"Efficacy of co-immunization with the DNA and peptide vaccines containing SYCP1 and ACRBP epitopes in a murine triple-negative breast cancer model","volume":"17","author":"Safavi","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.intimp.2023.109728_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105872","article-title":"Production, purification, and in vivo evaluation of a novel multiepitope peptide vaccine consisted of immunodominant epitopes of SYCP1 and ACRBP antigens as a prophylactic melanoma vaccine","volume":"76","author":"Safavi","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109728_b0330","doi-asserted-by":"crossref","first-page":"23121","DOI":"10.1038\/s41598-021-01770-w","article-title":"Immunoprotective effect of an in silico designed multiepitope cancer vaccine with BORIS cancer-testis antigen target in a murine mammary carcinoma model","volume":"11","author":"Mahdevar","year":"2021","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.intimp.2023.109728_b0335","first-page":"1895","article-title":"Thermostability and aliphatic index of globular proteins","volume":"88","author":"Ikai","year":"1980","journal-title":"J. Biochem."},{"issue":"14","key":"10.1016\/j.intimp.2023.109728_b0340","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.1080\/07391102.2021.1883111","article-title":"Exploring the cancer-testis antigen BORIS to design a novel multi-epitope vaccine against breast cancer based on immunoinformatics approaches","volume":"40","author":"Mahdevar","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"48","key":"10.1016\/j.intimp.2023.109728_b0345","doi-asserted-by":"crossref","first-page":"7612","DOI":"10.1016\/j.vaccine.2020.10.016","article-title":"Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches","volume":"38","author":"Safavi","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2023.109728_b0350","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.molimm.2019.04.030","article-title":"In silico analysis of transmembrane protein 31 (TMEM31) antigen to design novel multiepitope peptide and DNA cancer vaccines against melanoma","volume":"112","author":"Safavi","year":"2019","journal-title":"Mol. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.109728_b0355","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s10989-018-9780-z","article-title":"In silico analysis of synaptonemal complex Protein 1 (SYCP1) and Acrosin Binding Protein (ACRBP) antigens to design novel multiepitope peptide cancer vaccine against breast cancer","volume":"25","author":"Safavi","year":"2019","journal-title":"Int. J. Pept. Res. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2023.109728_b0360","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"issue":"10","key":"10.1016\/j.intimp.2023.109728_b0365","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41577-021-00592-1","article-title":"Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape","volume":"21","author":"Tregoning","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2023.109728_b0370","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.830497","article-title":"Peptide-based vaccines for tuberculosis","volume":"13","author":"Gong","year":"2022","journal-title":"Front Immunol."},{"issue":"1393","key":"10.1016\/j.intimp.2023.109728_b0375","article-title":"Peptides-based vaccine MP3RT induced protective immunity against mycobacterium tuberculosis infection in a humanized mouse model","volume":"12","author":"Gong","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2023.109728_b0380","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41576-021-00431-y","article-title":"Computational analysis of cancer genome sequencing data","volume":"23","author":"Cort\u00e9s-Ciriano","year":"2022","journal-title":"Nat. Rev. Genet."},{"issue":"7","key":"10.1016\/j.intimp.2023.109728_b0385","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41592-020-0848-2","article-title":"Macromolecular modeling and design in Rosetta: recent methods and frameworks","volume":"17","author":"Leman","year":"2020","journal-title":"Nat. Methods"},{"issue":"9","key":"10.1016\/j.intimp.2023.109728_b0390","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1016\/S1473-3099(20)30327-3","article-title":"The value of antimicrobial peptides in the age of resistance","volume":"20","author":"Magana","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.intimp.2023.109728_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.197984","article-title":"Combination of three adjuvants enhances the immunogenicity of a recombinant protein containing the CTL epitopes of non-structural proteins of hepatitis C virus","volume":"284","author":"Kuprianov","year":"2020","journal-title":"Virus Res."},{"key":"10.1016\/j.intimp.2023.109728_b0400","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.3389\/fimmu.2020.01165","article-title":"Peptide vaccine combined adjuvants modulate anti-tumor effects of radiation in glioblastoma mouse model","volume":"11","author":"Tran","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.109728_b0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105837","article-title":"Development of a chimeric vaccine candidate based on Toxoplasma gondii major surface antigen 1 and apicoplast proteins using comprehensive immunoinformatics approaches","volume":"162","author":"Asghari","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.intimp.2023.109728_b0410","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1038\/s41401-021-00820-3","article-title":"Lupeol protects against cardiac hypertrophy via TLR4-PI3K-Akt-NF-\u03baB pathways","volume":"43","author":"Li","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.intimp.2023.109728_b0415","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1002\/jmv.26826","article-title":"Role of Toll-like receptors in the pathogenesis of COVID-19","volume":"93","author":"Khanmohammadi","year":"2021","journal-title":"J. Med. Virol."},{"issue":"61","key":"10.1016\/j.intimp.2023.109728_b0420","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abh3634","article-title":"A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M\u2013052-alum adjuvant promotes protective efficacy in non-human primates","volume":"6","author":"Pino","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.intimp.2023.109728_b0425","unstructured":"M. Silva et al., A particulate saponin\/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity, Sci. Immunol. 6(66) (2021) eabf1152."},{"issue":"3","key":"10.1016\/j.intimp.2023.109728_b0430","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.immuni.2022.01.003","article-title":"Interferon-\u03b3 primes macrophages for pathogen ligand-induced killing via a caspase-8 and mitochondrial cell death pathway","volume":"55","author":"Simpson","year":"2022","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.intimp.2023.109728_b0435","article-title":"Multiepitope-based subunit vaccine design and evaluation against respiratory syncytial virus using reverse vaccinology approach","volume":"8","author":"Qamar","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.intimp.2023.109728_b0440","doi-asserted-by":"crossref","first-page":"15983","DOI":"10.1038\/s41598-022-20397-z","article-title":"Novel multi epitope-based vaccine against monkeypox virus: vaccinomic approach","volume":"12","author":"Shantier","year":"2022","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.intimp.2023.109728_b0445","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/187153007782794371","article-title":"Protein structure based strategies for antigen discovery and vaccine development against malaria and other pathogens","volume":"7","author":"Corradin","year":"2007","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"issue":"5","key":"10.1016\/j.intimp.2023.109728_b0450","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/jmv.27588","article-title":"Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines","volume":"94","author":"Araf","year":"2022","journal-title":"J. Med. Virol."},{"issue":"7","key":"10.1016\/j.intimp.2023.109728_b0455","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41556-021-00712-y","article-title":"SARS-CoV-2 targets MAVS for immune evasion","volume":"23","author":"Zotta","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.intimp.2023.109728_b0460","doi-asserted-by":"crossref","unstructured":"D.M.G. Halpin et al., Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD Science Committee Report on COVID-19 and chronic obstructive pulmonary disease, Am. J. Respir. Crit. Care Med. 203(1) (2021) 24\u201336.","DOI":"10.1164\/rccm.202009-3533SO"},{"issue":"2","key":"10.1016\/j.intimp.2023.109728_b0465","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/S1473-3099(20)30773-8","article-title":"What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2","volume":"21","author":"Hodgson","year":"2021","journal-title":"Lancet Infect. Dis."},{"issue":"3","key":"10.1016\/j.intimp.2023.109728_b0470","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V'Kovski","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.intimp.2023.109728_b0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2022.102459","article-title":"Diagnosis of monkeypox virus \u2013 an overview","volume":"50","author":"Altindis","year":"2022","journal-title":"Travel Med. Infect. Dis."},{"issue":"11","key":"10.1016\/j.intimp.2023.109728_b0480","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jamaneurol.2022.3491","article-title":"Neurologic complications of smallpox and monkeypox: a review","volume":"79","author":"Billioux","year":"2022","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.intimp.2023.109728_b0485","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41392-022-01215-4","article-title":"Monkeypox: epidemiology, pathogenesis, treatment and prevention","volume":"7","author":"Huang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2023.109728_b0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2022.102386","article-title":"New challenges in human monkeypox outside Africa: A review and case report from Italy","volume":"49","author":"Mileto","year":"2022","journal-title":"Travel Med. Infect. Dis."},{"issue":"6","key":"10.1016\/j.intimp.2023.109728_b0495","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1002\/jmv.27554","article-title":"The emerging roles of the CDK\/cyclin complexes in antiviral innate immunity","volume":"94","author":"Zheng","year":"2022","journal-title":"J. Med. Virol."},{"issue":"6","key":"10.1016\/j.intimp.2023.109728_b0500","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cell.2020.02.041","article-title":"Toll-like receptors and the control of immunity","volume":"180","author":"Fitzgerald","year":"2020","journal-title":"Cell"},{"issue":"40","key":"10.1016\/j.intimp.2023.109728_b0505","doi-asserted-by":"crossref","first-page":"37692","DOI":"10.1074\/jbc.M105927200","article-title":"Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells","volume":"276","author":"Re","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2023.109728_b0510","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/eji.200535467","article-title":"Preferential production of the IL-12(p40)\/IL-23(p19) heterodimer by dendritic cells from human newborns","volume":"36","author":"Vanden Eijnden","year":"2006","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2023.109728_b0515","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1039\/C4FO01065E","article-title":"Impact of soyasaponin I on TLR2 and TLR4 induced inflammation in the MUTZ-3-cell model","volume":"6","author":"Fu\u00dfbroich","year":"2015","journal-title":"Food Funct."},{"issue":"6","key":"10.1016\/j.intimp.2023.109728_b0520","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/1753425914564172","article-title":"Monophosphoryl lipid A inhibits the cytokine response of endothelial cells challenged with LPS","volume":"21","author":"Stark","year":"2015","journal-title":"Innate Immun."},{"key":"10.1016\/j.intimp.2023.109728_b0525","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13601-015-0086-3","article-title":"Expression profiling and functional analysis of Toll-like receptors in primary healthy human nasal epithelial cells shows no correlation and a refractory LPS response","volume":"5","author":"van Tongeren","year":"2015","journal-title":"Clin. Transl. Allergy"},{"key":"10.1016\/j.intimp.2023.109728_b0530","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejphar.2016.06.026","article-title":"A novel PPAR\u03b1 agonist propane-2-sulfonic acid octadec-9-enyl-amide inhibits inflammation in THP-1 cells","volume":"788","author":"Zhao","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2023.109728_b0535","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","article-title":"The T cell immune response against SARS-CoV-2","volume":"23","author":"Moss","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2023.109728_b0540","doi-asserted-by":"crossref","unstructured":"T.N. Schumacher, D.S. Thommen, Tertiary lymphoid structures in cancer, Science 375(6576) (2022) eabf9419.","DOI":"10.1126\/science.abf9419"},{"key":"10.1016\/j.intimp.2023.109728_b0545","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.molimm.2021.12.013","article-title":"Spotlight on TAP and its vital role in antigen presentation and cross-presentation","volume":"142","author":"Mantel","year":"2022","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2023.109728_b0550","article-title":"CD4(+) T cell activation and inflammation in NASH-related fibrosis","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Immunol."},{"issue":"17","key":"10.1016\/j.intimp.2023.109728_b0555","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1016\/j.cell.2022.07.004","article-title":"From rare disorders of immunity to common determinants of infection: following the mechanistic thread","volume":"185","author":"Casanova","year":"2022","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.intimp.2023.109728_b0560","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/jmv.27405","article-title":"Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19","volume":"94","author":"Manik","year":"2022","journal-title":"J. Med. Virol."},{"issue":"4","key":"10.1016\/j.intimp.2023.109728_b0565","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1039\/D1CS00417D","article-title":"Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future","volume":"51","author":"Sen","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"10","key":"10.1016\/j.intimp.2023.109728_b0570","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41577-022-00680-w","article-title":"Engineering IL-2 for immunotherapy of autoimmunity and cancer","volume":"22","author":"Hernandez","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2023.109728_b0575","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41584-021-00707-x","article-title":"Interleukin-2 and regulatory T cells in rheumatic diseases","volume":"17","author":"Kolios","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"issue":"4","key":"10.1016\/j.intimp.2023.109728_b0580","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","article-title":"Harnessing cytokines and chemokines for cancer therapy","volume":"19","author":"Propper","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923000516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923000516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:55:53Z","timestamp":1778619353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923000516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":116,"alternative-id":["S1567576923000516"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109728","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developing a multiepitope vaccine for the prevention of SARS-CoV-2 and monkeypox virus co-infection: A reverse vaccinology analysis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109728","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109728"}}